Limitations, agreements, and source contact

A Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib · Source last updated 2026-02-05

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

false

restrictive Agreement

false

point Of Contact

email

clinicaltrials@deciphera.com

organization

Deciphera Pharmaceuticals, LLC

phone

781-209-6400

title

INTRIGUE Clinical Team

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice